CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: An immunohistochemical survey of 476 primary and metastatic carcinomas

American Journal of Surgical Pathology

Volumn 27, Issue 3, 2003, Pages 303-310

  Werling, Robert W ^a   Yaziji, Hadi ^a   Bacchi, Carlos E ^b   Gown, Allen M ^a  

^a PHENOPATH LABORATORIES   (United States)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Carcinomas of unknown primary; Colonic adenocarcinoma; Immunohistochemistry; Nuclear transcription factor

Indexed keywords

CYTOSKELETON PROTEIN; MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR; TUMOR MARKER; VILLIN;

ADENOCARCINOMA; ADULT; ARTICLE; CDX2 GENE; COLON ADENOCARCINOMA; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FETUS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOMEOBOX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE CARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; PROTEIN EXPRESSION; TISSUE SPECIFICITY;

ADENOCARCINOMA; ADULT; CARRIER PROTEINS; FETUS; GASTROINTESTINAL NEOPLASMS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINES; MICROFILAMENT PROTEINS; SENSITIVITY AND SPECIFICITY; TRANS-ACTIVATORS;

EID: 0037371192     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200303000-00003     Document Type: Article

References (26)

1. Bacchi CE, Gown AM. Distribution and pattern of expression of villin, a gastrointestinal-associated cytoskeletal protein, in human carcinomas: a study employing paraffin-embedded tissue. Lab Invest 1991;64:418-24.
2. Bai YQ, Yamamoto H, Akiyama Y, et al. Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach. Cancer Lett 2002;176:47-55.
3. Beck F, Chawengsaksophak K, Waring P, et al. Reprogramming of intestinal differentiation and intercalary regeneration in Cdx2 mutant mice. Proc Natl Acad Sci USA 1999;96:7318-23.
4. Berezowski K, Stastny JF, Kornstein MJ. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod Pathol 1996;9:426-9.
5. Chawengsaksophak K, James R, Hammond VE, et al. Homeosis and intestinal tumors in Cdx2 mutant mice. Nature 1997;386:84-7.
6. Dias P, Parham DM, Shapiro DN, et al. Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma. Am J Pathol 1990;137:1283-91.
7. Drummond F, Putt W, Fox M, et al. Cloning and chromosome assignment of the human CDX2 gene. Ann Hum Genet 1997;61: 393-400.
8. Fabbro D, Di L-C, Beltrami CA, et al. Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms. Cancer Res 1994;54:4744-9.
9. Fabbro D, Di L-C, Stamerra O, et al. TTF-1 gene expression in human lung tumors. Eur J Cancer 1996;3:512-7.
10. Glavind K, Grove A. Estrogen and progesterone receptors in epithelial ovarian tumors. APMIS 1990;98:916-20.
11. Hinoi T, Tani M, Lucas PC, et al. Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am J Pathol 2001; 159:2239-48.
12. Kaufmann O, Kother S, Dietel M. Use of antibodies against estrogen and progesterone receptors to identify metastatic breast and ovarian carcinomas by conventional immunohistochemical and tyramide signal amplification methods. Mod Pathol 1998;11: 357-63.
13. Lazzaro D, Price M, de Felice M, et al. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the fetal brain. Development 1991;113: 1093-104.
14. Mallo GV, Soubeyran P, Lissitzky JC, et al. Expression of the Cdx1 and Cdx2 homeotic genes leads to reduced malignancy in colon cancer-derived cells. J Biol Chem 1998;273:14030-6.
15. Mallo GV, Rechreche H, Frigerio JM, et al. Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Downregulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis. Int J Cancer 1997;74: 35-44.
16. Moll R, Robine S, Dudouet B, et al. Villin: a cytoskeletal protein and a differentiation marker expressed in some human adenocarcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol 1987;54: 155-69.
17. Murer B, Chilosi M, Barbareschi M, et al. Cdx-2 is a specific and sensitive marker of tumors of colonic origin. Mod Pathol 2002;5: 325A-6A.
18. Nambu Y, Iannettoni MD, Orringer MB, et al. Unique expression patterns and alterations in the intestinal protein villin in primary and metastatic pulmonary adenocarcinomas. Mol Carcinog 1998; 23:234-42.
19. Sivagnanasundaram S, Islam I, Talbot I, et al. The homeobox gene CDX2 in colorectal carcinoma: a genetic analysis. Br J Cancer 2001;84:218-25.
20. Tamai Y, Nakajima R, Ishikawa T, et al. Colonic hamartoma development by anomalous duplication in Cdx2 knockout mice. Cancer Res 1999;59:2965-70.
21. Torenbeek R, Lagendijk JH, Van Diest PJ, et al. Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma. Histopathology 1998;32:20-7.
22. Wang N-P, Zee S, Zarbo RJ, et al. Coordinate expression of cytokeratins 7 and 20 define unique subsets of carcinoma. Appl Immunohistochem 1995;3:99-107.
23. Wang NP, Marx J, McNutt MA, et al. Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood. Am J Pathol 1995;147:1799-810.
24. West AB, Isaac CA, Carboni JM, et al. Localization of villin, a cytoskeletal protein specific to microvilli, in human ileum and colon and in colonic neoplasms. Gastroenterology 1988;94: 343-52.
25. Wicking C, Simms LA, Evans T, et al. CDX2, a human homologue of Drosophila caudal, is mutated in both alleles in a replication error positive colorectal cancer. Oncogene 1998;17:657-9.
26. Yagi OK, Akiyama Y, Yuasa Y. Genomic structure and alterations of homeobox gene CDX2 in colorectal carcinomas. Br J Cancer 1999;79:440-4.